Naunyn Hall

It’s about time: addressing the need for timely treatment intensification in type 2 diabetes mellitus

Evening Session

Guntram Schernthaner (Austria)
Welcome and objectives
Ralph DeFronzo (USA)
Time to focus: the SGLT2i paradigm in glycaemic management
John Wilding (UK)
Type 2 diabetes: the epidemic of our time – managing the future
Guntram Schernthaner (Austria), Ralph DeFronzo (USA), John Wilding (UK)
Time to act: panel discussion
Symposia by: